INTRODUCTION
Upper gastrointestinal bleeding (UGIB) is a com mon medical emergency. Incidence rates of UGIB demonstrate variations ranging from 48 to 160 cases per 100000 population [1] . The most common causes of acute UGIB are nonvariceal, where 28% to 59% are caused by peptic ulcer bleeding (PUB) [13] . Endoscopic hemostasis represents the cornerstone of UGIB treat ment, and several scores have been developed for the prediction of clinical intervention (i.e. Rockall score (RS), GlasgowBlatchford score (GBS), Baylor bleeding score (BBS), CedarsSinai Medical Center predictive index, Almela score, AIMS65 score) [414] . The recently published American College of Gastroenterology practice guidelines on the management of patients with ulcer bleeding recommend risk assessment in all patients in order to stratify them into high or low risk categories, since it may assist in initial decisions regarding the timing of endoscopy, time of discharge, and level of care [15] . The GBS is a preendoscopic score and contains the following parameters: initial hemoglobin levels, urea, blood pressure, pulse, known syncope, melena, and liver or cardiac failure. Each variable has an appointed numeric value and the maximal number of points is 23 ( Table 1 ). The GBS was designed to predict lower risk bleeds, and a GBS value of 1 or lower indicates very low risk category [8, 9] . The most commonly used RS consists of a preendoscopic evaluation part, which includes age, signs of shock and comorbidities, along with an endoscopic part, which evaluates highrisk endoscopic characteristics as well (known as the post endoscopic RS) ( Table 2 ). Each variable is appointed a numeric value and every value > 2 indicates a high risk patient [7] . The maximal preendoscopic RS value is 7, and the maximal postendoscopic value is 11. The postendoscopic RS can be calculated if bleeding is diagnosed and evaluated with upper endoscopy [7, 16, 17] . The BBS contains a preendoscopic evaluation part, which includes age, severity and duration of associated diseases, along with a postendoscopic part, which evaluates the position and type of fresh bleeding (Table  3) . The maximal preendoscopic BBS is 15, and the maximum total (preendoscopic and postendoscopic) BBS is 24 [18] . The RS was primarily developed to predict mortality and the GBS to evaluate need for clinical intervention [614] . Secondarily, they can be applied to asses rebleeding risk. The BBS was primarily developed to identify patients at high risk for rebleeding after endoscopic hemostasis [6, 16] . In previous studies, the GBS has been shown to be better than the pre endoscopic and postendoscopic RS in predicting the need for hospitalbased intervention in patients with UGIB [6, 13, 19] . On the other hand, the RS appeared to be better at predicting mortality after rebleeding, contributing to more accurate diagnostics and shorter hospital stay [7, 13, 14] . Recent studies have shown that early endoscopy (within 24 h of presentation) is performed in only half of patients with UGIB, demonstrating the need for reliable and accurate pre endoscopic risk assessment [615, 2025] . This is the first prospective study in Croatia to include over 1000 patients with PUB, and the aim was to compare the GBS, preendoscopic RS and preendoscopic BBS, as well as the postendoscopic RS and postendoscopic BBS, in the prediction of PUB treatment outcome, need for hospitalbased intervention (endoscopic treatment, transfusion, surgery intervention) or 30d mortality, including 30d rebleeding rate, 30d mortality rate, and needs for surgical intervention and blood transfusion, and to find optimal cutoff values that indicate highrisk patients.
MATERIALS AND METHODS
This prospective study was conducted in the University Hospital Center "Sestre Milosrdnice" that covers a population of approximately 300000 in the City of Zagreb, Croatia. All patients presenting to the Emergency Unit between January 2008 and December 2013 with hematemesis, melena, hematochezia, or blood admixture upon nasogastric insertion were considered for study enrolment. If initial workup indicated the need for hospitalization, patients were admitted to the Interventional Gastroenterology Unit.
Upper gastrointestinal endoscopy was performed in all patients within 24 h of admission. Only patients with gastric and/or duodenal ulcers, or an ulcer at the site of gastroenteric anastomosis found during emergency endoscopy, without any other possible cause of bleeding were included in the study. All patients with highrisk ulcer stigmata and patients selected depending on clinical judgment received highdose acid suppression therapy (pantoprazole or esomeprazole 80 mg as an intravenous bolus, followed by 40 mg intravenously 2 times daily or 200 mg daily in the form of continuous infusion for at least 48 h followed by 40 mg daily by mouth). The institution' s ethics committee approved the study. Data was prospectively entered into a database, with patient details stored in a depersonalized manner to protect patient confidentiality.
Data collection
The following data were collected for each patient: demographic data, history of ulcer or liver disease, coexisting and past illnesses, medication use, clinical characteristics of the bleeding episode, laboratory results, endoscopic diagnosis including stigmata of ongoing or recent hemorrhage, endoscopic interven tion, medical treatment, rebleeding, surgical therapy, duration of hospitalization and cause of death. The grading of overall health and comorbidity was performed according to the American Society of Anesthesiology (ASA) classification (grade 1, normal healthy patients; grade 2, mild systemic illness; grade 3, severe but incapacitating systemic illness; grade 4, lifethreatening illness). Stigmata of hemorrhage were defined according to the Forrest classification (Forrest Ia, spurting bleeding; Forrest Ib, oozing bleeding; Forrest Ⅱa, non-bleeding visible vessel; Forrest Ⅱ b, adherent clot; Forrest Ⅱc, hematin on ulcer base; Forrest Ⅲ, clean ulcer base).
Shock was defined as syncope or signs of shock at physical examination, including systolic blood pressure less than 100 mmHg and pulse rate more than 100 beats/min.
Posthemorrhagic anemia was corrected with red blood cell transfusion (2 units, approximately 500 ml) at a hemoglobin threshold of 7080 g/l.
All patients diagnosed with PUB and highrisk stigmata underwent initial hemostasis (injection of dilute epinephrine into and around the bleeding point, positioning of clips or thermal coagulation, or both, but never epinephrine alone). Two biopsy specimens were obtained from the gastric antrum and body in all patients and the presence of Helicobacter pylori (H. pylori) infection was assessed by histopathological examination of the specimens using hematoxylineosin (HE) stain.
All patients with negative histology for H. pylori at index endoscopy had a control endoscopy with repeating biopsy samples, or urea breath test (UBT), performed 2 wk after protonpump inhibitor treatment was discontinued. Patients in whom the described protocol was not followed were excluded from the study about H. pylori infection. of variance test were used to analyze differences in quantitative data. The discriminative ability of the scoring systems to predict outcomes was evaluated by receiver operating characteristics curves (ROC) with 95%CI. The areas under ROC (AUROC) curves were compared using the method of Delong et al [26] ( 1988) for the calculation of the standard error of the Area Under the Curve (AUC) and of the difference between two AUCs. The optimal thresholds of the GBS, RS and BBS for the prediction of rebleeding, death, and needs for blood transfusion and/or surgical intervention were identified as the threshold associated with the highest Youden index [27] . A twotailed significance level of 5% was used in all comparisons. All analyses were performed using a statistical package MedCalc for Windows, version 15.8 (MedCalc Software, Ostend, Belgium).
RESULTS
The analysis included 2643 patients with UGIB, of that 2326 (88%) patients had nonvariceal bleeding, 225 (8.5%) had variceal bleeding, and 92 (3.5%) had an unidentified cause of bleeding. From 2418 patients with non-variceal bleeding, 41.9% (1012) had PUB; specifically, the cause of bleeding in 49% (496) was gastric ulcer, in 47% (476) duodenal ulcer, in 2.4% (24) both gastric and duodenal ulcer, and in 1.6% (16) gastroenteric anastomosis ulcer. Endoscopic treatment was required in 58% of Rebleeding was defined as one or more signs of recurrent bleeding, including fresh hematemesis or melena, hematochezia, aspiration of fresh blood via nasogastric tube, instability of vital signs, and reduction of hemoglobin levels by 2 g/dl or more, occurring 24h after the primary bleeding was stopped.
For all patients with gastric ulcer in whom recurrent bleeding was not observed, control endoscopy was performed 45 d after initial hemostasis and biopsy specimens were obtained from the margins and base of gastric ulcers to exclude malignancy. Control endoscopy with histology had been planned to be performed in all patients with gastric ulcer.
Documented clinical outcomes were: need for hospitalbased intervention or 30d mortality, 30d rebleeding, 30d mortality and interventions (transfer to the Department of Surgery and the need for blood transfusion).
The collected data was used to calculate the GBS score, as well as the preendoscopic RS and pre endoscopic BBS for each patient presenting with UGIB. The postendoscopic RS and BBS were calculated if bleeding from gastric, duodenal or gastroenteric ulcers was endoscopically diagnosed. Methods for calculating the GBS, RS and BBS were as previously described. Preendoscopic and postendoscopic scores were separately evaluated.
Statistical analysis
The MannWhitney Utest and KruskalWallis analysis Table 4 shows the patient characteristics and clinical outcomes.
Using ROC curve analysis we found that the GBS was clearly superior to preendoscopic RS and pre endoscopic BBS, in predicting need for hospitalbased intervention or 30d mortality (AUROC 0.84 vs 0.57 vs 0.64 respectively) (Figure 1) .
The cutoff value that maximized the sum of the sensitivity and specificity for predicting 30-d mortality for the pre-endoscopic RS was 4 (sensitivity 0.63, specificity 0.85, total 1.48), and 5 for the postendoscopic RS (sensitivity 0.83, specificity 0.68, total 1.51).
Based on ROC analysis of sensitivity and specificity, the optimal cutoff value of the preendoscopic BBS for 30-d mortality was 8 (0.63 sensitivity, 0.58 specificity, total 1.21), and the optimal cutoff postendoscopic BBS value for 30d mortality was 9 (0.88 sensitivity, 0.40 specificity, total 1.28).
When assessing scores for the prediction of lethal outcome in patients with PUB, the preendoscopic RS was superior compared to the GBS and the pre endoscopic BBS (AUROC 0.82 vs 0.67 vs 0.63, respectively) ( Figure 2A ). Based on the ROC analysis of sensitivity and specificity, the optimal cutoff GBS value for 30d mortality was 12 (0.49 sensitivity, 0.75 specificity, total 1.24), for rebleeding 11 (0.71 sensitivity, 0.67 specificity, total 1.38), for blood transfusion 9 (0.71 sensitivity, 0.67 specificity, total 1.38) and for surgery 12 (0.71 sensitivity, 0.76 specificity, total 1.47).
The GBS score was superior to the preendoscopic RS and BBS in the prediction of rebleeding (AUROC 0.75 vs 0.61 vs 0.52) ( Figure 2B ).
The GBS score was superior to the preendoscopic RS and BBS in predicting the need for blood trans fusion (AUROC 0.83 vs 0.63 vs 0.59, respectively) ( Figure 2C ) and transfer to the Department of Surgery (AUROC 0.82 vs 0.63 vs 0.52, respectively) ( Figure  2D) . Also, the postendoscopic RS was superior to the postendoscopic BBS (AUROC 0.82 vs 0.69) in the prediction of lethal outcome ( Figure 3A) .
There was no significant difference between the postendoscopic RS and BBS in the prediction of rebleeding (AUROC 0.70 vs 0.73) ( Figure 3B ). The rebleeding cutoff point that maximized the sum of the sensitivity and specificity for the pre-endoscopic BBS was 3 (sensitivity 0.90, specificity 0.19, total 1.09), and 11 for the postendoscopic BBS (sensitivity 0.66, specificity 0.76, total 1.42).
There was no significant difference between the postendoscopic RS and BBS in predicting the need for blood transfusion (AUROC 0.68 vs 0.71) ( Figure 3C ) and transfer to the Department of Surgery (AUROC 0.68 vs 0.74) ( Figure 3D ).
DISCUSSION
UGIB is the most important cause of emergency gastroenterological admissions and the most frequent condition requiring emergency endoscopy [1] . The most common causes of acute UGIB are nonvariceal, of which 30% to 60% are attributed to PUB [28] . In our study, 42% of all nonvariceal bleeding was caused by PUB. In order to assess the adequate timing of endoscopy and selection of patients for hospital admission, several scoring systems for risk estimation have been developed. With the array of available scoring systems, it is often difficult to select the ideal scoring system for a particular patient or clinical outcome of interest. Therefore, in this study, we compared the performance of these scoring systems in the risk assessment of various clinical outcomes. Our study showed that the GBS is superior to the preendoscopic RS and BBS in predicting need for hospitalbased intervention or 30d mortality. This is in concordance with the results from a study by laursen [22] and a study by Bryant et al [19] . Our study also showed that the GBS is superior to the pre endoscopic RS and BBS in predicting peptic ulcer rebleeding. An explanation for why the GBS best predicts peptic ulcer rebleeding is that it incorporates hemoglobin and serum urea values. Serum urea is a good biochemical marker for UGIB because it rises rapidly when there is catabolism of isoleucinepoor hemoglobin [8, 29] . The maximal level of hemoglobin and urea account for half of the maximal sum of points in the GBS score.
Our study showed that there is no significant difference between the postendoscopic BBS and post endoscopic RS in predicting peptic ulcer rebleeding. This is in concordance with the results from a study by laursen et al [6] . Similar data was published by Italian and Dutch researchers, who also found low values under the ROC curve [(0.590.68) and 0.61] and concluded that the RS is not appropriate for prediction of rebleeding [16, 30] . Our study showed that the GBS is superior to the preendoscopic RS and preendoscopic BBS in predicting the needs for blood transfusion and/or transfer to the Department of Surgery. The ROC curve for GBS rebleeding was similar to the GBS ROC curve for blood transfusion requirement and transfer to the Department of Surgery because peptic ulcer rebleeding is the main cause of blood transfusion requirement and need for surgical intervention. Bryant et al [19] published similar data. Our study showed that the preendoscopic RS was superior to the GBS and preendoscopic BBS in predicting mortality. The RS best predicted fatal outcome because it incorporated the majority of risk factors (age, shock, moderate to severe comorbidities and highrisk endoscopic signs for rebleeding), which was valuable in a multivariate analysis of risk for fatal outcome [7, 13, 30, 31] . Our study showed that the post endoscopic RS is superior to the postendoscopic BBS in predicting lethal outcome in patients with PUB. laursen [22] did not find any significant difference in AUROC among postendoscopic BBS and post endoscopic RS. According to studies by Hyett et al [14] and Bryant et al [19] , the GBS cutoff points for highrisk of lethal outcome and rebleeding were ≥ 10 and ≥ 12, respectively. In a recent retrospective study, lim et al [32] suggested urgent endoscopy in the first 13
h after clinical presentation in highrisk patients with GBS > 12, in the first 24 h in patients with GBS > 7 and for patients with GBS values between 4 and 7 urgent endoscopy in the first 24 h is recommended, but not necessary. Our cutoff points for highrisk of rebleeding and lethal outcome in PUB patients are significantly different in comparison with original research papers (GBS ≥ 2, preendoscopic BBS > 5, postendoscopic BBS ≥ 10, postendoscopic RS ≥ 4), which all refer to UGIB [69, 13, 14] . An explanation for this could be that the original series included an unselected group of patients with UGIB, with a significant proportion of patients with a lowrisk of death, recurrent bleeding, and needs for blood transfusion and/or surgical intervention. These were patients that presented with lowrisk bleeding ulcers (Forrest Ⅱc and Forrest Ⅲ), Mallory Weiss syndrome, ulcerative esophagitis, angiodysplasia and portal hypertensive gastropathy.
When considering possible limitations of our study, there is always a certain level of subjectivity in the endoscopic classification of ulcers and variation in endoscopic treatment. Furthermore, our study had a relatively short followup period of 30 d.
By comparing the ROC curves of the aforemen tioned preendoscopic scores, the RS proved to be the best score for predicting lethal outcome. The postendoscopic RS was also better than the post endoscopic BBS in predicting lethal outcome in pati ents with PUB. On the other hand, among the three preendoscopic scores, the GBS best predicted need for hospitalbased intervention or 30d mortality, rebleeding, and needs for blood transfusion and/or surgical intervention.
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